Charles River Laboratories International, Inc.
CRL
Rang in Aktien
#1504
Charles River Laboratories International, Inc. operates as a contract research... Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Aktienkurs
$300.30
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$14.46B
Veränderung (1 Tag)
-1.89%
Veränderung (1 Jahr)
68.22%
Land
US
Handel Charles River Laboratories International, Inc. (CRL)
Kategorie
Healthcare
Operative Marge für Charles River Laboratories International, Inc. (CRL)
Operative Marge zum October 2026 TTM: 12.35%
Laut den neuesten Finanzberichten und dem Aktienkurs von Charles River Laboratories International, Inc. beträgt die aktuelle operative Marge (TTM) 12.35%. Am Ende des Jahres 2023 lag die operative Marge bei 14.95%.
Historie der operativen Marge von Charles River Laboratories International, Inc. von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 12.35% | 120.14% |
| 2024 | 5.61% | -62.47% |
| 2023 | 14.95% | -8.67% |
| 2022 | 16.37% | -1.74% |
| 2021 | 16.66% | 12.57% |
| 2020 | 14.80% | 10.45% |
| 2019 | 13.40% | -8.34% |
| 2018 | 14.62% | -5.80% |
| 2017 | 15.52% | 9.84% |
| 2016 | 14.13% | -6.67% |
| 2015 | 15.14% | 10.59% |
| 2014 | 13.69% | 5.39% |
| 2013 | 12.99% | -11.51% |
| 2012 | 14.68% | -3.74% |
| 2011 | 15.25% | -157.90% |
| 2010 | -26.34% | -286.81% |
| 2009 | 14.10% | -142.11% |
| 2008 | -33.48% | -281.37% |
| 2007 | 18.46% | 3.82% |
| 2006 | 17.78% | 8.02% |
| 2005 | 16.46% | -20.10% |
| 2004 | 20.60% | -8.77% |
| 2003 | 22.58% | 2.45% |
| 2002 | 22.04% | 13.67% |
| 2001 | 19.39% | -8.62% |
| 2000 | 21.22% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 17.97% | -98.54% |
US
|
|
| 20.42% | -98.35% |
US
|
|
| -10.70% | -100.87% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.20% |
US
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.